Literature DB >> 16941352

Low levels of RANTES are associated with mortality in children with cerebral malaria.

Chandy C John1, Robert Opika-Opoka, Justus Byarugaba, Richard Idro, Michael J Boivin.   

Abstract

BACKGROUND: In children with cerebral malaria (CM), serum chemokine levels and associated morbidity and mortality have not been characterized.
METHODS: Serum levels of the cytokines interleukin (IL)-1 beta , IL-6, IL-10, interferon (IFN)-gamma, and tumor necrosis factor-alpha and the chemokines macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, and regulated upon activation, normal T cell expressed and secreted (RANTES) were measured in Ugandan children with CM, in children with uncomplicated malaria (UM), and in healthy children from the community, as control subjects (CCs).
RESULTS: Children with CM had lower levels of RANTES and higher levels of all other cytokines and chemokines than CCs (all P<.0001), and they had lower levels of RANTES (P=.004) and higher levels of IL-10 (P=.003), IFN-gamma (P=.007), and IL-1 beta (P=.05) than children with UM. Children with CM who died had lower levels of RANTES (P=.006) and higher of levels of IL-6 (P=.006), IL-10 (P=.01), IFN-gamma (P=.03), and MIP-1 beta (P=.008) than children who survived. After adjustment for other cytokine and chemokine levels, only low levels of RANTES were independently associated with mortality (P=.016). Levels of RANTES correlated with platelet count but were associated with mortality independently of platelet count.
CONCLUSIONS: The serum cytokine and chemokine profile of children who die of CM is similar to that of individuals who die of sepsis. Levels of RANTES are significantly lower in children with CM, and very low levels of RANTES are associated with mortality, independently of other cytokine and chemokine levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941352     DOI: 10.1086/506623

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Plasma cell-free DNA predicts pediatric cerebral malaria severity.

Authors:  Iset Medina Vera; Anne Kessler; Li-Min Ting; Visopo Harawa; Thomas Keller; Dylan Allen; Madi Njie; McKenze Moss; Monica Soko; Ajisa Ahmadu; Innocent Kadwala; Stephen Ray; Tonney S Nyirenda; Wilson L Mandala; Terrie E Taylor; Stephen J Rogerson; Karl B Seydel; Kami Kim
Journal:  JCI Insight       Date:  2020-06-18

2.  Evaluating Immunopathogenic Biomarkers During Severe Malaria Illness as Modifiers of the Neuropsychologic Benefits of Computer Cognitive Games Rehabilitation in Ugandan Children.

Authors:  Michael J Boivin; Alla Sikorskii; Noeline Nakasujja; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Robert O Opoka; Bruno Giordani
Journal:  Pediatr Infect Dis J       Date:  2019-08       Impact factor: 2.129

3.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

4.  TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria.

Authors:  Nadia A Sam-Agudu; Jennifer A Greene; Robert O Opoka; James W Kazura; Michael J Boivin; Peter A Zimmerman; Melissa A Riedesel; Tracy L Bergemann; Lisa A Schimmenti; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 5.  Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria.

Authors:  Miriam Canavese; Roberta Spaccapelo
Journal:  Pathog Glob Health       Date:  2014-03-07       Impact factor: 2.894

6.  Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria.

Authors:  Fiona E Lovegrove; Sina A Gharib; Samir N Patel; Cheryl A Hawkes; Kevin C Kain; W Conrad Liles
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

7.  Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.

Authors:  Chandy C John; Gregory S Park; Nadia Sam-Agudu; Robert O Opoka; Michael J Boivin
Journal:  Cytokine       Date:  2008-02-20       Impact factor: 3.861

8.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Authors:  Gabriele S V Campanella; Andrew M Tager; Joseph K El Khoury; Seddon Y Thomas; Tabitha A Abrazinski; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

9.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Authors:  Fiona E Lovegrove; Noppadon Tangpukdee; Robert O Opoka; Erin I Lafferty; Nimerta Rajwans; Michael Hawkes; Srivicha Krudsood; Sornchai Looareesuwan; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.